Superdisintegrants Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 8.10 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Superdisintegrants Market Analysis
The superdisintegrants market studied was expected to grow with a CAGR of approximately 8.1% over the forecast period. The major factors accrediting to the growth of the market are increasing adoption of orally disintegrating tablets, and increasing healthcare expenditure and awareness. Furthermore, the increasing number of pediatric patients and the geriatric population cannot swallow solid forms of medication. These agents are used as a viscosity-improving agent in drug-loaded films, having improved performance, and maintains high drug content uniformity. Superdisintegrants are added to solid dosage forms such as capsules or tablets that aids them to disintegrate when submerged in liquid. Due to this benefit, these are significantly used in the manufacturing of disintegrating oral formulations, which further increases the demand for superdisintegrants in the market. However, the concerns related to safety and quality are the major drawback of market growth.
Superdisintegrants Market Trends
This section covers the major market trends shaping the Superdisintegrants Market according to our research experts:
Natural Superdisintegrants segment to register significant growth
- Natural superdisintegrants such as ispaghulla, gellan gum, fenugreek seed mucilage, and gum karaya, among others have many advantages over synthetic superdisintegrants, such as biodegradability, chemical inertness, and non-toxicity. Moreover, it can be modified in several ways in order to obtain tailor-made materials for drug delivery systems that aim to enhance safety by the formulation of an accessible dosage.
- The major factors propelling the segment growth are the increasing number of pediatric patients and the geriatric population, expansion of generic drugs market, increase of new superdisintegrants.
.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall superdisintegrants market, throughout the forecast period. The market growth is due to factors such as the presence of key players, established healthcare infrastructure, and availability of funding for research and development for advanced drug delivery methods. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase market growth. In this region, the United States has the maximum share due to supportive healthcare policies, the high number of patients, and a developed healthcare market
Superdisintegrants Industry Overview
The Superdisintegrants market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market BASF SE, Ashland Global Holdings Inc., DuPont., Roquette Freres, DFE Pharma, JRS Pharma, Asahi Kasei Corporation, Merck KGaA, and Corel Pharma Chem.
Superdisintegrants Market Leaders
-
BASF SE
-
Ashland Global Holdings Inc.
-
DuPont
-
Roquette Freres
-
DFE Pharma
*Disclaimer: Major Players sorted in no particular order
Superdisintegrants Market News
In March 2021 the Formulationbio had announced the Launch of Disintegrant Excipients for Pharmaceutical Preparation.
In July 2018 the company DFE Pharma, has successfully optimized its supply chain of pharmaceutical excipients. In addition, the company has invested heavily in capacity expansion at their factories to meet the global demand for high-quality excipients including pharmaceutical grade Lactose and Microcrystalline Cellulose (MCC).
Superdisintegrants Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Adoption of Orally Disintegrating Tablets
4.2.2 Increase Healthcare Expenditure and Awareness
4.2.3 Rising Prevalence Of Chronic Conditions With Increasing Number Of Pediatric And Geriatric Population
4.3 Market Restraints
4.3.1 Concerns About the Safety and Quality of Product
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Natural Superdisintegrants
5.1.2 Synthetic Superdisintegrants
5.1.2.1 Modified Starch
5.1.2.2 Modified Cellulose
5.1.2.3 Crospovidone
5.1.2.4 Calcium Silicates
5.1.2.5 Ion Exchange Resins
5.1.3 Others
5.2 By Formulation
5.2.1 Tablets
5.2.2 Capsules
5.3 By Therapeutic Area
5.3.1 Neurological Diseases
5.3.2 Gastrointestinal Diseases
5.3.3 Oncology
5.3.4 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Rest of World
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 BASF SE
6.1.2 Ashland Global Holdings Inc.
6.1.3 DuPont
6.1.4 Roquette Freres
6.1.5 DFE Pharma
6.1.6 JRS Pharma
6.1.7 Asahi Kasei Corporation
6.1.8 Merck KGaA
6.1.9 Corel Pharma Chem
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Superdisintegrants Industry Segmentation
As per the scope of the report, superdisintegrant is a kind of excipient that is used for the tablet-based drug delivery in the pharmaceutical industry. This report is segmented by Product Type, by Formulation, by Therapeutic Area, and by Geography.
| By Product Type | |||||||
| Natural Superdisintegrants | |||||||
| |||||||
| Others |
| By Formulation | |
| Tablets | |
| Capsules |
| By Therapeutic Area | |
| Neurological Diseases | |
| Gastrointestinal Diseases | |
| Oncology | |
| Others |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| Rest of World |
Superdisintegrants Market Research FAQs
What is the current Superdisintegrants Market size?
The Superdisintegrants Market is projected to register a CAGR of 8.10% during the forecast period (2024-2029)
Who are the key players in Superdisintegrants Market?
BASF SE, Ashland Global Holdings Inc., DuPont, Roquette Freres and DFE Pharma are the major companies operating in the Superdisintegrants Market.
Which is the fastest growing region in Superdisintegrants Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Superdisintegrants Market?
In 2024, the North America accounts for the largest market share in Superdisintegrants Market.
What years does this Superdisintegrants Market cover?
The report covers the Superdisintegrants Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Superdisintegrants Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Superdisintegrants Industry Report
Statistics for the 2023 Superdisintegrants market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Superdisintegrants analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
